PTGX
Protagonist Therapeutics Inc
$25.57
Earnings Summary
Revenue | $60Mn |
Net Profits | $27.34Mn |
Net Profit Margins | 45.56% |
Highlights
Protagonist Therapeutics Inc’s revenue jumped +Inf% since last year same period to $60Mn in the Q4 2023. On a quarterly growth basis, Protagonist Therapeutics Inc has generated +Inf% jump in its revenue since last 3-months.
Protagonist Therapeutics Inc’s net profit jumped 187.37% since last year same period to $27.34Mn in the Q4 2023. On a quarterly growth basis, Protagonist Therapeutics Inc has generated 180.15% jump in its net profits since last 3-months.
Protagonist Therapeutics Inc’s net profit margin jumped NaN% since last year same period to 45.56% in the Q4 2023. On a quarterly growth basis, Protagonist Therapeutics Inc has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Protagonist Therapeutics Inc post its latest quarter earnings
EPS Estimate Current Quarter | 1.19 |
EPS Estimate Current Year | 1.19 |
Highlights
Protagonist Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at 1.19 - a 4066.67% jump from last quarter’s estimates.
Protagonist Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at 1.19.
Key Ratios
Key ratios of the Protagonist Therapeutics Inc post its Q4 2023 earnings
Earning Per Share (EPS) | 0.44 |
Highlights
Protagonist Therapeutics Inc’s earning per share (EPS) jumped 163.77% since last year same period to 0.44 in the Q4 2023. This indicates that the Protagonist Therapeutics Inc has generated 163.77% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-02-27 | -0.03 | 0.44 | 1566.67% |
2023-11-02 | -0.69 | -0.58 | 15.94% |
2023-05-04 | -0.73 | -0.67 | 8.22% |
2023-08-03 | -0.65 | -0.68 | -4.62% |
₹0 US Stocks a/c Opening Fee